EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience

Céline Khouri, Julie Tandonnet, Laure Saumet, Lee Aymar Ndounga-Diakou, Nadege Corradini, Ludovic Mansuy, Morgane Cleirec, Hélène Sudour-Bonnange, Natacha Entz-Werle, Emmanuelle Gardiest, Yves Reguerre, Sébastian Klein und 5 weitere

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116904 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Céline Khouri und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Adolescent Oncology, Gustave-Roussy, Université Paris-Saclay, Villejuif, France. Hauptthemen laut MEDLINE: Pyrazoles, Pyrimidines, Oncogene Proteins, Fusion, Protein Kinase Inhibitors. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesPyrimidinesOncogene Proteins, FusionProtein Kinase InhibitorsNeoplasmsHumansFemaleMaleChildChild, PreschoolAdolescentInfantFranceYoung AdultProspective StudiesFibrosarcomaReceptor, trkA

Stichwörter der Autor:innen

CNS tumorsInfantile fibrosarcomaLarotrectinibNTRK fusionPediatric oncologyPrecision oncologyReal-world dataSoft tissue sarcoma

Substanzen

larotrectinibPyrazolesPyrimidinesOncogene Proteins, FusionProtein Kinase InhibitorsReceptor, trkA

Autor:innen und Institutionen

  • Department of Pediatric and Adolescent Oncology, Gustave-Roussy, Université Paris-Saclay, Villejuif, France.
  • Department of Pediatric Oncology and Hematology, Bordeaux University Hospital, Bordeaux, France.
  • Department of Pediatric Onco-Hematology, Montpellier University Hospital, Montpellier, France.
  • Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
  • Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
  • Department of Pediatric Haematology and Oncology, Children's University Hospital, Nancy, France.

Zitieren

APA

Khouri, C., Tandonnet, J., Saumet, L., Ndounga-Diakou, L. A., Corradini, N., Mansuy, L., Cleirec, M., Sudour-Bonnange, H., Entz-Werle, N., Gardiest, E., Reguerre, Y., Klein, S., Serre, J., Laghouati, S., Minard-Colin, V., Orbach, D., & Berlanga, P. (2026). Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116904

Vancouver

Khouri C, Tandonnet J, Saumet L, Ndounga-Diakou LA, Corradini N, Mansuy L, et al. Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116904

BibTeX
@article{Khouri2026,
  author = {Khouri, Céline and Tandonnet, Julie and Saumet, Laure and Ndounga-Diakou, Lee Aymar and Corradini, Nadege and Mansuy, Ludovic and Cleirec, Morgane and Sudour-Bonnange, Hélène and Entz-Werle, Natacha and Gardiest, Emmanuelle and Reguerre, Yves and Klein, Sébastian and Serre, Jill and Laghouati, Salim and Minard-Colin, Véronique and Orbach, Daniel and Berlanga, Pablo},
  title = {Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116904}
}
Kostenlos starten →